Sample Preparation Market is Expected to Reach a Valuation of US$ 8.3 Billion by 2024
“Regulatory requirements for testing substances, chemicals, and pharmaceuticals are only becoming more complex with every passing year. This, combined with the fact that most samples cannot be introduced or injected directly into the analytical instrument, makes a strong case for the demand for sample preparation technologies and instruments. No matter how sophisticated sample preparation technologies and instruments get, there is always going to be space to introduce more efficient products, making the sample preparation market dynamic in both the long and short term,” said a TMR analyst.
Read Report Overview @ https://www.transparencymarketresearch.com/sample-preparation-market.html
Investor sentiment remains very positive in the biotechnology and life sciences sectors in nearly every emerging market worldwide. Global leaders in the healthcare industry are investing an overwhelming majority of their R&D budgets in pharmaceuticals and diagnostics. This unmistakable emphasis on R&D by the market leaders has prompted other competitors in the market to follow suit. Thus, TMR estimates that this keen inclination toward drug discovery and biosimilars will also give the sample preparation market a shot in the arm.
At the same time, new breakthroughs in technologies to make sample preparation quicker and more convenient are aiding the market’s growth. Recent advances in equipment, such as automation, and techniques, such as solid supported liquid-liquid extraction, have been crucial to the positive growth posted by the sample preparation market globally. The launch of kits and consumables for specialized and niche studies also bodes well for the sample preparation market, notes TMR.
The intensive investments in R&D into new sample preparation equipment and technologies, prompted by the stiff competition in this market, forces companies to pass on some portion of the costs to consumers. The impact of this is especially evident in emerging countries where consumers look toward used equipment in keeping with their modest budgets. Investments in cost-intensive upgrades are often deferred or entirely canned in several cases because consumers are concerned about erosion of investments with the continuous evolution of sample preparation equipment and techniques. However, TMR expects that the advent of national and regional genome projects could open a door of opportunity for companies in the sample preparation market.
The global sample preparation market was valued at US$4.6 bn in 2015 and is expected to reach a valuation of US$8.3 bn by 2024, exhibiting a CAGR of 6.6% from 2016 to 2024. Sample preparation instruments constituted the largest share of the global sample preparation market in 2015 as compared to other sample preparation products. Their efficiency in addressing high-throughput requirements of the sample preparation industry can be credited for their leading position. Consumables trail the instruments segment in terms of growth.
TMR states that pharmaceutical companies-thanks to their heavy reliance on sample preparation through the drug development process-will be the key end-user segment in the global sample preparation market. However, molecular diagnostic laboratories are expected to show a high single-digit CAGR through the report’s forecast period.
Request Sample Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3855
On the basis of application, the use of sample preparation in genomics is expected to generate the highest revenue. Between 2016 and 2024, however, the epigenomics segment will register an 8.0% CAGR, which is the highest among all application segments. By geography, North America is expected to maintain a lead in terms of revenue until 2024, whereas Asia Pacific will have the highest CAGR at 8.0% between 2016 and 2024.
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Sample Preparation Market is Expected to Reach a Valuation of US$ 8.3 Billion by 2024 here
News-ID: 830143 • Views: 243
More Releases from TMR - Research Reports
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment
More Releases for R&D
High Performance Hovercraft Market - R&D Activities Opening New Opportunities
A hovercraft, also known as an air-cushion vehicle or ACV, is an amphibious craft capable of travelling over land, water, mud, ice, and other surfaces. In 2018, the market size of High Performance Hovercraft is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2018; while in China, the market size is valued at xx million US$ and will increase to
R&D Collaborative Projects by GD Rectifiers
GD Rectifiers have extensive experience in collaborative R&D projects and are proud to work with some of the UK’s pioneering power electronic companies to drive design and innovation forward. This R&D service helps drive GD Rectifiers forward as a cutting edge manufacturer embracing fundamental technologies that support product development that contribute to next generation products throughout: renewable energy, embedded systems, smart metrering and the rail industry. Power Assemblies, Controllers and
Transforming Pharmaceutical R&D with Data
ReportsWorldwide has announced the addition of a new report title Transforming Pharmaceutical R&D with Data to its growing collection of premium market research reports. Transforming Pharmaceutical R&D with Data In the current drug pricing environment, biopharmaceutical firms cannot afford to continue spending billions of dollars on development programs that are more than 90% likely to fail. Raising prices to compensate for expensive, risky research and development (R&D) is no longer an option
Noliac is expanding the R&D team
Noliac is looking for two new colleagues for the R&D team in Prague, Czech Republic: A Precision/Fine Mechanics and an Electroengineer. Precision/Fine Mechanics For the R&D team in Prague, Czech Republic, Noliac is looking for a Precision/Fine mechanics to work on modifying existing products and work with developing new. Noliac requires a colleague who: Is mechanically skilled with a focus on very small machinery. Holds a technical high school degree or an apprenticeship
Leiber GmbH further invests in R&D
Since February 2016, Leiber GmbH has been reinforced by Dr med vet Claudia Westfahl - a veterinarian specialized in animal nutrition - as part of the company's strategy to invest in new product developments. With the new position ‘Product Development Animal Nutrition’, Dr Westfahl is responsible for new product development in the field of functional feed ingredients for both pet as well as farm animals. After graduating at the University
Rising R&D Funding for Nanotechnology
Global nanotechnology market has been registering marked increase in funds allocation by the countries across the world, especially with new product development that received huge momentum due to these funding. An increase in global public funding for R&D initiatives supports quick commercialization of nano-based products. Fundings from governments, corporations, and venture capital exhibited a CAGR growth of 1% during 2008-2012. In future, it is expected that nanotechnology funding will grow